Evonik Evonik

X

Find Reldesemtiv manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Reldesemtiv
Also known as: Ck-2127107, 1345410-31-2, Reldesemtiv [usan], 4s0hbyw6qe, Reldesemtiv (usan), 1-[2-({[trans-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methyl}amino)pyrimidin-5-yl]-1h-pyrrole-3- carboxamide
Molecular Formula
C19H18F2N6O
Molecular Weight
384.4  g/mol
InChI Key
MQXWPWOCXGARRK-UHFFFAOYSA-N
FDA UNII
4S0HBYW6QE

Reldesemtiv is under investigation in clinical trial NCT03160898 (A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)).
1 2D Structure

Reldesemtiv

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[2-[[3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methylamino]pyrimidin-5-yl]pyrrole-3-carboxamide
2.1.2 InChI
InChI=1S/C19H18F2N6O/c20-13-6-19(7-13,16-15(21)2-1-4-23-16)11-26-18-24-8-14(9-25-18)27-5-3-12(10-27)17(22)28/h1-5,8-10,13H,6-7,11H2,(H2,22,28)(H,24,25,26)
2.1.3 InChI Key
MQXWPWOCXGARRK-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1C(CC1(CNC2=NC=C(C=N2)N3C=CC(=C3)C(=O)N)C4=C(C=CC=N4)F)F
2.2 Other Identifiers
2.2.1 UNII
4S0HBYW6QE
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(2-((3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)methylamino)pyrimidin-5-yl)pyrrole-3-carboxamide

2. Ck-2127107

2.3.2 Depositor-Supplied Synonyms

1. Ck-2127107

2. 1345410-31-2

3. Reldesemtiv [usan]

4. 4s0hbyw6qe

5. Reldesemtiv (usan)

6. 1-[2-({[trans-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methyl}amino)pyrimidin-5-yl]-1h-pyrrole-3- Carboxamide

7. 1-[2-[[3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methylamino]pyrimidin-5-yl]pyrrole-3-carboxamide

8. 1h-pyrrole-3-carboxamide, 1-(2-(((trans-3-fluoro-1-(3-fluoro-2-pyridinyl)cyclobutyl)methyl)amino)-5-pyrimidinyl)-

9. Unii-4s0hbyw6qe

10. Reldesemtiv [inn]

11. Schembl2566240

12. Chembl4297600

13. Schembl12288022

14. Schembl17584804

15. Gtpl11801

16. Ck-107

17. Db15256

18. Ck2127107

19. Hy-109121

20. Cs-0078343

21. J3.610.548h

22. D11363

23. 1-(2-(((trans-3-fluoro-1-(3-fluoro-2-pyridinyl)cyclobutyl)methyl)amino)-5-pyrimidinyl)- 1h-pyrrole-3-carboxamide

24. 1-(2-(((trans-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)methyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide

25. 1-[2-[[[3alpha-fluoro-1beta-(3-fluoro-2-pyridyl)cyclobutane-1-yl]methyl]amino]pyrimidine-5-yl]-1h-pyrrole-3-carboxamide

26. 1-[2-[[[trans-3-fluoro-1-(3-fluoro-2-pyridinyl)cyclobutyl]methyl]amino]-5-pyrimidinyl]-1h-pyrrole-3-carboxamide

2.4 Create Date
2012-11-30
3 Chemical and Physical Properties
Molecular Weight 384.4 g/mol
Molecular Formula C19H18F2N6O
XLogP31.5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count6
Exact Mass384.15101554 g/mol
Monoisotopic Mass384.15101554 g/mol
Topological Polar Surface Area98.7 Ų
Heavy Atom Count28
Formal Charge0
Complexity553
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of amyotrophic lateral sclerosis


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY